Skip to main content
Shenzhen Chipscreen Biosciences Co., Ltd. logo

Shenzhen Chipscreen Biosciences Co., Ltd. — Investor Relations & Filings

Ticker · 688321 ISIN · CNE100003LW0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 967 across all filing types
Latest filing 2023-11-27 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688321

About Shenzhen Chipscreen Biosciences Co., Ltd.

https://www.chipscreen.com/en/

Shenzhen Chipscreen Biosciences Co., Ltd. specializes in the discovery and development of original small molecule innovative drugs. The company leverages its proprietary chemical genomics-based drug discovery and early evaluation platform to address unmet medical needs in oncology, metabolic diseases, and autoimmune disorders. Its portfolio includes Chidamide (Epidaza), a selective histone deacetylase (HDAC) inhibitor approved for peripheral T-cell lymphoma and advanced breast cancer, and Chiglitazar (Bilessyl), a novel PPAR pan-agonist for type 2 diabetes. Chipscreen Biosciences maintains an integrated R&D system covering drug discovery, clinical development, and commercialization, focusing on molecular mechanisms and translational medicine to provide novel therapeutic solutions.

Recent filings

Filing Released Lang Actions
董事会审计委员会工作细则（2023年11月修订）
Governance Information Classification · 95% confidence The document is titled as the "Board Audit Committee Working Rules" of Shenzhen Microchip Biotechnology Co., Ltd. It details the structure, responsibilities, meeting procedures, and operational rules of the audit committee under the board of directors. There is no financial data, no report of financial results, no announcement of voting results, no executive changes, no legal proceedings, no capital updates, and no earnings information. The document is a governance-related internal rules document describing the audit committee's governance framework and procedures. Therefore, it fits best under Governance Information (CGR). The document length is 3922 characters, which is sufficient for a detailed governance document and not a mere announcement or certification.
2023-11-27 Chinese
公司章程（2023年11月修订）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association) of Shenzhen Chipscreen Biosciences Co., Ltd., dated November 2023. It contains detailed company governance rules, shareholder rights, board structure, share issuance, share transfer, and other organizational and operational regulations. It is a comprehensive governance document outlining the internal rules and structure of the company rather than a financial report or announcement. There is no indication that this is an annual report, audit report, earnings release, or any other financial or regulatory filing. The content matches the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2023-11-27 Chinese
独立董事工作制度（2023年11月修订）
Governance Information Classification · 100% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the governance structure, qualifications, nomination, rights, duties, and operational procedures for independent directors of the company. It references relevant laws and regulations such as the Company Law of the People's Republic of China and the China Securities Regulatory Commission's management measures. The content is focused on governance practices and internal rules regarding independent directors rather than financial performance, audit results, or shareholder meeting materials. There is no indication of financial data, earnings, voting results, or legal proceedings. The document is a governance-related policy document outlining internal rules and practices for the board's independent directors. Therefore, it fits best under Governance Information (CGR). The document length is sufficient and it is not a brief announcement or certification, so it is not RPA or RNS.
2023-11-27 Chinese
第二届董事会第三十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board of directors meeting of Shenzhen Microchip Biotechnology Co., Ltd. It includes information about board meeting attendance, voting results on various governance-related proposals such as amendments to company bylaws, nomination of directors, and committee adjustments. The document references the need for shareholder approval at an upcoming extraordinary general meeting but does not itself contain financial data or earnings information. It is not a full annual or interim report, nor an earnings release or audit report. The content focuses on board and management decisions and governance matters. Therefore, the document fits best into the category of Board/Management Information (MANG). The document length is 4181 characters, which is sufficient for a detailed board meeting resolution announcement. Confidence is high due to the clear focus on board resolutions and governance changes.
2023-11-27 Chinese
对外担保管理制度（2023年11月修订）
Governance Information Classification · 95% confidence The document is titled '深圳微芯生物科技股份有限公司 对外担保管理制度' which translates to 'Shenzhen Microcore Biotechnology Co., Ltd. External Guarantee Management System'. It is a detailed internal policy document outlining the company's procedures, responsibilities, and governance related to providing external guarantees. It references company governance, legal compliance, approval processes, and risk management related to guarantees. There is no indication that this is a financial report, regulatory filing, announcement, or any other specific filing type such as an annual report, earnings release, or management change. It is a governance-related internal rules document. Therefore, the most appropriate classification is Governance Information (CGR). The document length (5773 characters) and content confirm it is a substantive policy document, not a brief announcement or certification.
2023-11-27 Chinese
股东大会议事规则（2023年11月修订）
Governance Information Classification · 100% confidence The document is titled as "股东大会议事规则" which translates to "Rules of Procedure for the Shareholders' General Meeting" of Shenzhen Microchip Biotechnology Co., Ltd. The content extensively details the procedures, rules, and regulations governing the conduct, notification, proposal submission, voting, and record-keeping of shareholders' meetings. It does not contain financial statements, audit opinions, earnings data, or any report of financial performance. Instead, it is a governance document outlining internal rules and processes related to shareholder meetings. Therefore, it fits best under the category of Governance Information (CGR). The document length is sufficient and the content is substantive, not a mere announcement or notice, so it is not an RPA or RNS filing.
2023-11-27 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.